.png)
.png)
News
August 24, 2020
New England Journal of Medicine Publishes Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) ...
Read More...August 21, 2020
2020 NLA Scientific Sessions Going Virtual
The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel...
Read More...August 3, 2020
NLA LipidPALOOZA
The National Lipid Association is excited to announce a month-long extravaganza of virtual education, LipidPALOOZA,...
Read More...July 10, 2020
NLA Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
The NLA today announced the release of its official scientific statement on the use of genetic testing in dyslipidemia.
Read More...July 2, 2020
NLA's New Plan for Education in September
As we’ve monitored the trajectory of COVID-19 cases and local restrictions...
Read More...